235 related articles for article (PubMed ID: 30471748)
1. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
[TBL] [Abstract][Full Text] [Related]
4. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
5. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
[TBL] [Abstract][Full Text] [Related]
6. Combining multiparametric MRI features-based transfer learning and clinical parameters: application of machine learning for the differentiation of uterine sarcomas from atypical leiomyomas.
Dai M; Liu Y; Hu Y; Li G; Zhang J; Xiao Z; Lv F
Eur Radiol; 2022 Nov; 32(11):7988-7997. PubMed ID: 35583712
[TBL] [Abstract][Full Text] [Related]
7. Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an
Tsujikawa T; Yamamoto M; Shono K; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Okazawa H; Yoshida Y
Ann Nucl Med; 2017 Dec; 31(10):752-757. PubMed ID: 28905201
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
Dubreuil J; Tordo J; Rubello D; Giammarile F; Skanjeti A
Nucl Med Commun; 2017 Jan; 38(1):84-90. PubMed ID: 27898647
[TBL] [Abstract][Full Text] [Related]
9. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
[TBL] [Abstract][Full Text] [Related]
10. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment tumor SUV
Ha SC; Oh JS; Roh JL; Moon H; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):33-40. PubMed ID: 27448574
[TBL] [Abstract][Full Text] [Related]
14. Preliminary utilization of radiomics in differentiating uterine sarcoma from atypical leiomyoma: Comparison on diagnostic efficacy of MRI features and radiomic features.
Xie H; Hu J; Zhang X; Ma S; Liu Y; Wang X
Eur J Radiol; 2019 Jun; 115():39-45. PubMed ID: 31084757
[TBL] [Abstract][Full Text] [Related]
15. Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.
Kim H; Rha SE; Shin YR; Kim EH; Park SY; Lee SL; Lee A; Kim MR
Korean J Radiol; 2024 Jan; 25(1):43-54. PubMed ID: 38184768
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
[TBL] [Abstract][Full Text] [Related]
17. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
Ma Y; Shao X; Shao X; Wang X; Wang Y
Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of FDG PET/CT findings of uterine tumors.
Kitajima K; Murakami K; Kaji Y; Sugimura K
AJR Am J Roentgenol; 2010 Sep; 195(3):737-43. PubMed ID: 20729454
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
